GTS Securities’s LAVA Therapeutics LVTX Stock Holding History

GTS Securities’s Portfolio LVTX Stock Details LVTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-200,000	Closed	-$312K	–	1640
2025 Q3	$312K	Buy	+200,000	New	+$299K	0.01%	1009

GTS Securities's LVTX Position: Q4 2025 in Review

GTS Securities sold out of LAVA Therapeutics (LVTX) in Q4 2025, closing a stake of 200,000 shares — an estimated $312K sold.

GTS Securities first reported a position in LVTX in Q3 2025 and held it in 1 quarter. The position peaked at $312K in Q3 2025. 0 funds tracked by Wall St. Rank hold LVTX as of Q4 2025.

GTS Securities reported no remaining LAVA Therapeutics position as of Q4 2025 after selling out during the quarter.
GTS Securities sold 200,000 LAVA Therapeutics shares in Q4 2025, an estimated $312K.
GTS Securities first reported a position in LAVA Therapeutics in Q3 2025 and held it in 1 quarter.
GTS Securities's LAVA Therapeutics position peaked at $312K in Q3 2025.
0 funds tracked by Wall St. Rank held LAVA Therapeutics as of Q4 2025.

Based on GTS Securities's 13F filing for Q4 2025, filed 13 Feb 2026.